Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.1230
0.00 (0.00%)
At close: Apr 17, 2025, 4:00 PM
0.1145
-0.0085 (-6.91%)
After-hours: Apr 17, 2025, 4:47 PM EDT
Spruce Biosciences Employees
Spruce Biosciences had 29 employees as of December 31, 2023. The number of employees increased by 2 or 7.41% compared to the previous year.
Employees
29
Change (1Y)
2
Growth (1Y)
7.41%
Revenue / Employee
$169,345
Profits / Employee
-$1,828,828
Market Cap
5.01M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 29 | 2 | 7.41% |
Dec 31, 2022 | 27 | 12 | 80.00% |
Dec 31, 2021 | 15 | -2 | -11.76% |
Dec 31, 2020 | 17 | 2 | 13.33% |
Dec 31, 2019 | 15 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
SPRB News
- 3 days ago - Spruce Biosciences, Inc. (SPRB) Corporate Update Conference Call (Transcript) - Seeking Alpha
- 3 days ago - Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) - Business Wire
- 4 months ago - Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder - Benzinga
- 4 months ago - Spruce Biosciences to wind down investment for genetic disorder drug - Reuters
- 4 months ago - Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH - Business Wire
- 5 months ago - Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
- 5 months ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out - Accesswire
- 5 months ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Take Part - Accesswire